Literature DB >> 8858305

Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-Cl-IB-MECA in conscious rats.

E A Van Schaick1, K A Jacobson, H O Kim, A P IJzerman, M Danhof.   

Abstract

The hemodynamic effects of the novel, selective adenosine A3 receptor agonist 2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide (2-Cl-IB-MECA) were investigated in conscious rats. Intravenous administration of 200 micrograms/kg 2-Cl-IB-MECA resulted in a short-lasting hypotension, which was accompanied by a 50-100-fold increase in plasma histamine concentrations. Administration of a second dose of 2-Cl-IB-MECA did not elicit any hemodynamic effects. Also no histamine release was observed after the second dose. The observation of rapid tachyphylaxis in combination with histamine release suggests that mast cell mediator release plays a key role in the hemodynamic effects of adenosine A3 receptor agonists.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858305      PMCID: PMC4287249          DOI: 10.1016/0014-2999(96)00373-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

Review 1.  Adenosine receptor subtypes: characterization and therapeutic regulation.

Authors:  M E Olah; G L Stiles
Journal:  Annu Rev Pharmacol Toxicol       Date:  1995       Impact factor: 13.820

2.  The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells.

Authors:  V Ramkumar; G L Stiles; M A Beaven; H Ali
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

Review 3.  Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions.

Authors:  J Linden
Journal:  Trends Pharmacol Sci       Date:  1994-08       Impact factor: 14.819

4.  G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain.

Authors:  M P Abbracchio; R Brambilla; S Ceruti; H O Kim; D K von Lubitz; K A Jacobson; F Cattabeni
Journal:  Mol Pharmacol       Date:  1995-12       Impact factor: 4.436

5.  Nucleoside-induced arteriolar constriction: a mast cell-dependent response.

Authors:  M P Doyle; J Linden; B R Duling
Journal:  Am J Physiol       Date:  1994-05

6.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat.

Authors:  J P Hannon; H J Pfannkuche; J R Fozard
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

8.  A role for central A3-adenosine receptors. Mediation of behavioral depressant effects.

Authors:  K A Jacobson; O Nikodijević; D Shi; C Gallo-Rodriguez; M E Olah; G L Stiles; J W Daly
Journal:  FEBS Lett       Date:  1993-12-20       Impact factor: 4.124

9.  Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat.

Authors:  R A Mathôt; E A van Schaick; M W Langemeijer; W Soudijn; D D Breimer; A P Ijzerman; M Danhof
Journal:  J Pharmacol Exp Ther       Date:  1994-02       Impact factor: 4.030

10.  2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.

Authors:  H O Kim; X D Ji; S M Siddiqi; M E Olah; G L Stiles; K A Jacobson
Journal:  J Med Chem       Date:  1994-10-14       Impact factor: 7.446

View more
  13 in total

1.  Chapter 13. A3 Adenosine Receptors.

Authors:  Kenneth A Jacobson; Susanna Tchilibon; Bhalchandra V Joshi; Zhan-Guo Gao
Journal:  Annu Rep Med Chem       Date:  2003       Impact factor: 1.059

2.  Ability of CP-532,903 to protect mouse hearts from ischemia/reperfusion injury is dependent on expression of A3 adenosine receptors in cardiomyoyctes.

Authors:  Tina C Wan; Akihito Tampo; Wai-Meng Kwok; John A Auchampach
Journal:  Biochem Pharmacol       Date:  2019-01-30       Impact factor: 5.858

3.  A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs.

Authors:  John A Auchampach; Zhe-Dong Ge; Tina C Wan; Jeannine Moore; Garrett J Gross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04-10       Impact factor: 4.733

4.  NADPH oxidase pathway is involved in aortic contraction induced by A3 adenosine receptor in mice.

Authors:  Mohammed S El-Awady; Habib R Ansari; Daniel Fil; Stephen L Tilley; S Jamal Mustafa
Journal:  J Pharmacol Exp Ther       Date:  2011-05-23       Impact factor: 4.030

5.  Airway hyperresponsiveness to adenosine induced by lipopolysaccharide in Brown Norway rats.

Authors:  B Tigani; J P Hannon; C Rondeau; L Mazzoni; J R Fozard
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

6.  Evidence for an atypical receptor mediating the augmented bronchoconstrictor response to adenosine induced by allergen challenge in actively sensitized Brown Norway rats.

Authors:  J P Hannon; B Tigani; C Wolber; I Williams; L Mazzoni; C Howes; J R Fozard
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

7.  The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel.

Authors:  Tina C Wan; Zhi-Dong Ge; Akihito Tampo; Yasushi Mio; Martin W Bienengraeber; W Ross Tracey; Garrett J Gross; Wai-Meng Kwok; John A Auchampach
Journal:  J Pharmacol Exp Ther       Date:  2007-09-28       Impact factor: 4.030

8.  Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration.

Authors:  Irina M Fedorova; Marlene A Jacobson; Anthony Basile; Kenneth A Jacobson
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

9.  Probing the binding site of the A1 adenosine receptor reengineered for orthogonal recognition by tailored nucleosides.

Authors:  Krishnan K Palaniappan; Zhan-Guo Gao; Andrei A Ivanov; Rebecca Greaves; Hayamitsu Adachi; Pedro Besada; Hea Ok Kim; Ae Yil Kim; Seung Ah Choe; Lak Shin Jeong; Kenneth A Jacobson
Journal:  Biochemistry       Date:  2007-06-02       Impact factor: 3.162

Review 10.  G-Protein-Coupled Receptors and Ischemic Stroke: a Focus on Molecular Function and Therapeutic Potential.

Authors:  Zeinab Vahidinia; Mohammad Taghi Joghataei; Cordian Beyer; Mohammad Karimian; Abolfazl Azami Tameh
Journal:  Mol Neurobiol       Date:  2021-06-12       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.